Beijing Huafang Investment

NeuroDome is a manufacturer specializing in non-invasive deep brain nerve modulation technology. The company is dedicated to the research and development of innovative products that enhance neurosurgical practices. Its offerings include wearable medical instruments, medical imaging technology, and medical information systems, all designed to improve patient outcomes and minimize the risks associated with neurosurgery. By focusing on minimally invasive solutions, NeuroDome aims to advance the field of neurosurgery through its cutting-edge technological developments.

Bochuang Biotechnology is a pioneering developer of medical repair products focused on the electrochemical assembly of biomacromolecules. The company specializes in creating high-end biological tissue functional membranes and innovative medical devices aimed at addressing specific repair needs, such as those related to alveolar bone, membranes, and diseased corneas. Utilizing its unique biological macromolecule electrochemical deposition technology, Bochuang Biotechnology offers a range of advanced products, including artificial corneas, periosteum, dura mater, and nerve sheaths. These solutions are designed to provide restorative therapies for patients suffering from eye diseases and other medical conditions.

Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lower extremity atherosclerosis, and coronary heart disease bypass surgery.

Zenosic focuses in the design and R&D of high-performance network chips, along with offering leading chip products for cloud service providers, equipment makers, operators, and diverse industries.

Veritas Medicine is a pharmaceutical company that specializes in the development of innovative traditional medicine and CRO services.

Inkodi Electronics is a manufacturer of electronic components that specializes in integrated circuit design, chip R&D and design, analog circuit layout design, and electronic component retail.

Wiseetec is a company that specializes in semiconductor equipment research and development, manufacturing, and sales. The company has specialized in bonding and debonding equipment research and development. The product application encompasses the entire semiconductor field. It provides overall temporary bonding and permanent bonding solutions.

Rongcan Bio is a company focused on the development and industrialization of nucleic acid drugs, specifically mRNA-based pharmaceuticals. It offers a comprehensive range of services that encompass the entire nucleic acid industry chain, including nucleic acid sequence design, synthesis of mRNA raw materials, and the creation of delivery systems. By integrating these processes, Rongcan Bio aims to provide efficient drug delivery solutions for patients and establish itself as a leader in the nucleic acid therapeutics market.

Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.

Xinsu Technology develops, designs, and sells industrial machine vision sensor devices. It is specialized in new energy battery and automobile manufacturing industries. It engaged in intellectual property rights of decoding and reading algorithms and has launched a series of industrial high-performance fixed code readers such as R275-A.

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.

Tangshi Technology is a platform for research and development for carbon-based materials. It helps in creation, and use of conductive agents and negative electrode materials.

Chuangjian Medical is a technological innovation company that focuses on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines.

Converd is a biotechnology company specializing in the development of innovative cancer immunotherapies, particularly focused on oncolytic viruses. The company has established research and development platforms dedicated to creating new-generation virotherapies and is committed to exploring effective combinations of oncolytic viruses with other immunotherapeutic approaches. Converd's team comprises professionals with extensive expertise in the entire drug development process, from initial research to clinical application. Additionally, the company operates a research and development center equipped with a functional cytology laboratory and an experimental animal room, which supports its efforts in tumor immune-related technologies, including immune cell therapy and immune checkpoint antibodies. Through its advanced R&D capabilities, Converd aims to produce cutting-edge medicines to combat cancer.

FineImmu is a biotechnology company specializing in the development of cell therapy drugs and immunodiagnostic products aimed at treating tumors. The company focuses on individualized tumor immunotherapy and precise combination therapies, which enhance the efficacy of treatments for common malignant tumors. FineImmu's innovative technology assesses the anti-tumor immune function and therapeutic effects of immune checkpoint inhibitors, including PD-1, PD-L1, and CTLA4. By providing healthcare professionals with effective tools for rapid efficacy assessment and tailored treatment options, FineImmu strives to improve patient outcomes in cancer care.

Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.

Haimai Medical is a platform for tissue engineering and regenerative medicine technology. It focused on the development and manufacture of allogeneic small-caliber tissue-engineered blood vessels suitable for the establishment of chronic renal failure dialysis vascular access, lower extremity arterial trauma blood vessel replacement, lower extremity atherosclerosis, and coronary heart disease bypass surgery.